GHK-Cu — handling a copper complex, not a plain peptide
GHK-Cu is a tripeptide bound to a copper(II) ion. The metal changes the mass, the colour, the light sensitivity and what a purity figure even means.
GHK-Cu is the tripeptide glycyl-histidyl-lysine bound to a copper(II) ion, CAS 89030-95-5, molecular weight 402.92 g/mol including the metal. The copper is not a contaminant or an additive — it is part of the compound, and it changes the mass, the colour, the light sensitivity and how a purity figure should be read.
By the Bench Grade Research Team ·
GHK-Cu identity data
| Property | Value |
|---|---|
| CAS Registry Number | 89030-95-5 |
| Molecular formula | C14H24CuN6O4 |
| Molecular weight | 402.92 g/mol (complex, including copper) |
| Peptide portion | Gly-His-Lys |
| Metal centre | One Cu(II) ion per tripeptide |
| Common vial sizes | 50 mg, 100 mg |
GHK and GHK-Cu are different products
The uncomplexed tripeptide GHK and the copper complex GHK-Cu are sold under confusingly similar names. They have different molecular weights, because one includes a copper ion and the other does not, and a calculation done against the wrong figure is wrong by the mass of the metal.
The visual check is unusually reliable here. The copper complex is a distinct blue; the uncomplexed peptide is a white or off-white solid. A vial labelled GHK-Cu whose contents are white is worth querying before use.
What purity means for a metal complex
HPLC area percent measures the proportion of UV-absorbing material eluting as the main peak. For a metal complex this needs care: incomplete complexation leaves free peptide, and free peptide and complex do not necessarily resolve cleanly on every method. A high area percent does not by itself prove that all the peptide present is complexed.
This is the argument for asking what method was used rather than accepting the number alone — a question that separates suppliers who run their own analysis from those who forward a document.
Copper is the mechanism, not a passenger
The proposed mechanism for this complex is metal delivery. Copper is a required cofactor for lysyl oxidase, the enzyme that forms the cross-links giving collagen and elastin their mechanical properties, and the dermatological literature examines the complex as a vehicle for delivering it.
That makes this compound structurally unlike most in the catalog. A peptide acting at a receptor is a lock-and-key proposition; a peptide carrying a metal to an enzyme system is a transport proposition. Published work describes effects on collagen synthesis in cultured fibroblasts on that basis.
Why the tripeptide alone is a different proposition
If the copper is the active part, the uncomplexed tripeptide is not a weaker version of the same product — it is a different one, missing the component the mechanism is built on. That reframes the GHK versus GHK-Cu distinction covered above from a pricing question into a functional one.
It also explains why elemental analysis for copper content is a meaningful check here and meaningless for an ordinary peptide. For this compound the metal content is a specification, not a contaminant reading.
The oxidation catalysis nobody accounts for
Copper ions catalyse oxidation reactions. On its own that is a storage note; in a blend it is a compatibility question, because the copper complex and any oxidation-prone component share a vial, a solvent and a shelf.
Both KLOW and GLOW pair this complex with TB-500, which carries a methionine — the most oxidation-prone amino acid. Neither blend has been studied for that interaction, and the sensible response is to store the whole vial to the standard of its least tolerant component rather than to the average of them.
Light, pH and storage
- Copper complexes are generally more light-sensitive than plain peptides. Amber vials or dark storage matter more here than for a typical sequence.
- The complex is pH-dependent. In strongly acidic conditions the copper can dissociate, leaving free peptide and free copper ions rather than the intended compound.
- Copper ions catalyse oxidation of other species. In a blend containing oxidation-prone residues, the presence of a copper complex is a variable worth accounting for.
Reconstitution arithmetic for GHK-Cu
Vial sizes for this compound are an order of magnitude larger than for most research peptides — 50 mg and 100 mg rather than 5 mg — because the molecular weight is low. A 50 mg vial in 5 mL gives 10 mg/mL, which at 402.92 g/mol is about 24.8 mM: a far higher molar concentration than the same mass of a larger peptide would produce.
What the GHK-Cu literature examined
The peer-reviewed work on this compound spans dermatological and cell-culture research, including studies of the complex in tissue models. The research library on this site indexes the primary sources.
References
Primary literature for the compounds discussed above. Links open the record on PubMed.
- The potential of GHK as an anti-aging peptide Pickart L, et al. Aging Pathobiol Ther. 2022. PMID 35083444 → · summary
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data Pickart L, et al. Int J Mol Sci. 2018. PMID 29986520 → · summary
Primary sources
Frequently asked questions
- Is GHK-Cu the same as GHK?
- No. GHK is the uncomplexed tripeptide; GHK-Cu is that tripeptide bound to a copper(II) ion, with a different molecular weight of 402.92 g/mol. Calculations done against the wrong figure are off by the mass of the metal.
- Why is GHK-Cu blue?
- The colour comes from the copper(II) centre, which absorbs in the visible range. It is a useful identity check: a vial labelled GHK-Cu whose contents are white or off-white is likely the uncomplexed peptide rather than the complex.
- Does GHK-Cu need special storage?
- It benefits from darker storage than a typical peptide, because copper complexes are more light-sensitive. It is also pH-dependent — strongly acidic conditions can dissociate the copper, leaving free peptide and free copper rather than the intended compound.
Compounds discussed in this guide
More on identification
- Thymosin Alpha-1 — identity and the clinical literatureA 28-residue N-acetylated thymic peptide with more clinical literature behind it than almost any compound in this market. Identity data and what the studies covered.
- LL-37 (Cathelicidin) — identity and handling of a cationic peptide37 residues carrying an unusually high positive charge. That charge governs its solubility, its adsorption to surfaces, and why it needs different labware.
- PT-141 (Bremelanotide) — a cyclic peptide, and why that mattersBremelanotide is cyclised head-to-side-chain, not linear. The ring changes its stability, its analysis, and what a COA can and cannot confirm.
All products discussed in this guide are supplied by Bench Grade Peptides for laboratory research use only. Not for human or veterinary use.




